Association Between Systemic Immune-Inflammation Index and Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis
S Wang, G Zhang - Angiology, 2024 - journals.sagepub.com
The systemic immune-inflammation index (SII) has been developed for the risk
prognostication of acute coronary syndrome (ACS) patients. This meta-analysis aimed to …
prognostication of acute coronary syndrome (ACS) patients. This meta-analysis aimed to …
Deciphering the Enigma of Intramyocardial Hemorrhage Following Reperfusion Therapy in Acute ST-Segment Elevation Myocardial Infarction: A Comprehensive …
Y xin Yang, F Zhou, T Wen, W jing Li - Cardiology in Review, 2024 - journals.lww.com
Acute ST-segment elevation myocardial infarction (STEMI) is a formidable challenge in
cardiovascular medicine, demanding advanced reperfusion strategies such as emergency …
cardiovascular medicine, demanding advanced reperfusion strategies such as emergency …
Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third …
Background The frequency and prognostic value of coronary no-reflow (CNR) was
investigated in studies that have used an outdated reperfusion therapy in terms of stent …
investigated in studies that have used an outdated reperfusion therapy in terms of stent …
Special Issue “Coronary Artery Disease Interventions”
L Herold, GG Toth, D von Lewinski - Journal of Clinical Medicine, 2024 - mdpi.com
The treatment and burden of patients with severe ischemic heart disease, whether acute or
chronic, remain some of the greatest challenges in cardiology [1]. Accordingly, this Special …
chronic, remain some of the greatest challenges in cardiology [1]. Accordingly, this Special …
[HTML][HTML] Association of Pre-PCI Blood Pressure and No-Reflow in Patients with Acute ST-Elevation Coronary Infarction
X Li, C Yu, L Lei, X Liu, Y Chen, Y Wang, SF Qiu… - Global Heart, 2024 - ncbi.nlm.nih.gov
Background: Previous studies have established blood pressure (BP) as a pivotal factor
influencing no-reflow following primary percutaneous coronary intervention (PCI) in patients …
influencing no-reflow following primary percutaneous coronary intervention (PCI) in patients …
Inflamação e No-Reflow: Podem Mudar o Jogo?
AT Timóteo - Arquivos Brasileiros de Cardiologia, 2024 - SciELO Brasil
O no-reflow (NR) é uma possível complicação durante a intervenção coronária percutânea
(ICP), particularmente no contexto do infarto do miocárdio com elevação do segmento ST …
(ICP), particularmente no contexto do infarto do miocárdio com elevação do segmento ST …
The Contemporary Management and Coronary Angioplasty Outcomes in Young Patients with ST-Elevation Myocardial Infarction (STEMI) age< 40 years old: The …
P Porapakkham, P Porapakkham, S Srimahachota… - 2024 - researchsquare.com
Background Cardiovascular disease (CVD) remains one of the major causes of death
around the world in which ST elevation MI (STEMI) is in the lead. Although the mortality rate …
around the world in which ST elevation MI (STEMI) is in the lead. Although the mortality rate …
[PDF][PDF] KARDIOPROTEKTÍV STRATÉGIÁK A SZÍVIZOM ISZKÉMIÁS-REPERFÚZIÓS KÁROSODÁSÁVAL SZEMBEN
A Komócsi, I Szokodi - Sport-és Egészségtudományi füzetek, 2023 - journals.lib.pte.hu
Bevezetés: Az ST-szegment elevációval járó szívinfarktus (STEMI) előfordulása az elmúlt két
évtizedben a fejlett országokban csökkenést mutatott. A reperfúziós terápiához való széles …
évtizedben a fejlett országokban csökkenést mutatott. A reperfúziós terápiához való széles …